The purpose of the Quest Awards is to promote the discovery of promising new stem cell-based technologies that could be translated to enable broad use and ultimately, improve patient care. Applications should propose technology that is uniquely enabled by human stem/progenitor cells or directly reprogrammed cells, or that is uniquely enabling for the advancement of stem cell-based therapies.
The expected outcome, at the end of the award, is a candidate therapeutic, diagnostic, medical device, or tool that can immediately progress to our Translational Stage Programs.
Please visit the CIRM website for full details. Applications are due March 18th, 2021 at 2:00 PM PDT.